(Q46061276)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

Luigi Marzio Biasucci

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Silvia Riondino

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Giovanna Liuzzo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

12

Filippo Crea

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1

Fabio M Pulcinelli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

4

Simona Giubilato

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

11

Giovanni Ghirlanda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Andrea Leo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Livia Di Renzo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Elisabetta Trifirò

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Teresa Mattiello

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Dario Pitocco

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

3 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

published in

European Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

1279-1286

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346231%20AND%20SRC:MED&resulttype=core&format=json

Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP097

Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP097

Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP097

Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP097

Comparison of effectiveness of rosuvastatin versus atorvastatin on the achievement of combined C-reactive protein (<2 mg/L) and low-density lipoprotein cholesterol (< 70 mg/dl) targets in patients with type 2 diabetes mellitus (from the ANDROMEDA st

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP097

Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP097

Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP097

Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP097

More on aspirin resistance: position paper of the Working Group on Aspirin Resistance. Proposal for a Laboratory Test Guiding Algorithm

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP097

Aspirin resistance: position paper of the Working Group on Aspirin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP097

Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP097

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP097

A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP097

Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP097

Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP097

Platelet activation in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP097

Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP097

Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP097

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHP097

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346231%20AND%20SRC:MED&resulttype=core&format=json

release_r2bduzbi6bbqzlp66pcm33mv7q

25 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/r2bduzbi6bbqzlp66pcm33mv7q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference